广誉远中药股份有限公司2025年半年度报告摘要

Group 1 - The core viewpoint of the announcement is the assurance of the board of directors regarding the authenticity, accuracy, and completeness of the content, with legal responsibility for any false statements or omissions [2][3] - The board meeting was held on August 18, 2025, with all six directors present, complying with the relevant regulations of the Company Law and Articles of Association [2] - The 2025 semi-annual report and summary were approved by the board of directors after review by the audit committee, with unanimous support from all voting directors [2]